专家访谈

专题首页 » 专家访谈

⇔ [APASL2011]HCC Risk Prediction Scoring System Needs Further Validation 2011-02-23
⇔ [APASL2011]The Six Month Interval of HCC is Cost Effective-Interview with Prof. Massimo Colombo 2011-02-23
⇔ [APASL2011]Therapy Strategy for Patients with Hepatitis B Resistance-Interview with Prof. Lampertico 2011-02-23
⇔ [APASL2011]HCC Risk Factors Associated with Patients with Chronic Hepatitis B-Interview with Prof.Chan Pei Jer 2011-02-23
⇔ [APASL2011]Interview with Prof. Teerha Piratvisuth 2011-02-21
⇔ [APASL2011]Issues Associated with Anti-hepatitis B Viral Drug—Interview with Prof. Emmet B. Keeffe 2011-02-21
⇔ [APASL2011]Hepatitis B reactivation mechanism needs More study-Interview with Prof. Antonio Berloletti 2011-02-21
⇔ [APASL2011]The new diagnostic method of HCC——Interview with Professor M Omata from Tokyo university 2011-02-19
⇔ [APASL2011]Making Optimal Therapy Profile for HCC by Assessing a Patient’s Baseline Life Expectancy-Interview with Prof. Jordi Bruix 2011-02-19
⇔ [APASL2011]Hepatitis C Clinical Trial Results Mixed Picture——Interview with Professor JM.Pawlotsky 2011-02-19
⇔ [APASL2011]A Successful Experience for Reducing the Rate of HCC from Japan_ Interview with Ryosuke Tateishi 2011-02-19
⇔ [APASL2011]Application Prospects of Transient Elastography-Interview with Vincent WS Wong 2011-02-17
⇔ [APASL2011]The Role of Immune Control in Curing Patients with Chronic Hepatitis B-Interview with Harry Janssen 2011-02-17
⇔ [APASL2011]Anemia in Patients with Chronic Hepatitis C during Anti-viral Therapy ——Interview with Prof.Mitchell L. Shiffman 2011-02-17
⇔ [APASL2011]Present and Future Prospects for Drug Therapy of Hepatic——Encephalopathy-Interview with Dr Praveen Sharma 2011-02-17
⇔ [APASL2011]How to Overcome the Difficulties of Anti-fibrosis Therapy？--Interview with Jia 2011-02-17

首页 1 尾页

专家访谈

专题标签

学术领域

扫描二维码，用手机看今日话题